NATRELLE INSPIRA™ Represents Company’s Latest Innovation in Breast Implants Provides New Implant Option for Surgeons and Patients Seeking Reconstruction, Augmentation or Revision Surgery Allergan, Inc. (NYSE: AGN) announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRA™ round gel-filled smooth breast implants. The NATRELLE INSPIRA™ line is… Read more »








